ARTICLE | Clinical News
Fluarix Quadrivalent regulatory update
December 24, 2012 8:00 AM UTC
FDA approved GlaxoSmithKline's seasonal flu vaccine Fluarix Quadrivalent to prevent influenza subtypes A and type B infection in people >=3 years. According to GSK, the vaccine helps protect against t...